Maybe if I start from the beginning, I can make sense of what people mean when they call Finland “the happiest country in the ...

The strategy for treating multiple sclerosis (MS) is shifting from “preventing relapses” toward blocking disease progression ...

ViGenCell announced on Wednesday that it has recruited two executives to oversee business development and GMP operations to ...

Last year, Korea’s national health insurance system recorded a surplus of 499.6 billion won ($350.8 million) in its ...

Dong-A ST announced on Wednesday that Health Canada has granted marketing authorization for Imuldosa (ingredient: ustekinumab ...

Daiichi Sankyo Korea said Wednesday that its targeted therapy for acute myeloid leukemia (AML), Vanflyta (quizartinib), has ...

Concerns were raised that the range of medications available for treating severe obesity among children and adolescents ...

Boryung Consumer Healthcare announced on Wednesday that it held shareholders' and board of directors' meetings, appointing ...

SAN FRANCISCO, Calif. – By Hong Sook / Korea Biomedical Review correspondent -- Samjin Pharmaceutical, long known for its ...

The Korean treatment landscape for ovarian cancer is poised for a significant shift as the first antibody-drug conjugate (ADC ...

Noul, an AI-based blood and cancer diagnostics specialist, said Wednesday that it has signed a contract to supply its ...

HLB just put a second cancer program onto the FDA’s review track, this time aiming for an accelerated approval in bile duct ...